MedTrace Logo

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

NCT07405138 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-02-19

No results posted yet for this study

Summary

To study the effectiveness and safety of IPL treatment for Chalazion

Conditions

  • Chalazion

Interventions

DEVICE

Sham IPL

Three sham IPL treatments in 1-week interval followed by 1 follow-up 4 weeks after the last treatment

DEVICE

Active IPL

Three active IPL treatments in 1-week interval followed by 1 follow-up 4 weeks after the last treatment

Sponsors & Collaborators

  • Lumenis Be Ltd.

    lead INDUSTRY

Principal Investigators

  • James Chelnis, MD · Manhattan Face and Eye clinic

  • Laura Periman · Periman Eye Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-04
Primary Completion
2026-12-31
Completion
2026-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07405138 on ClinicalTrials.gov